2023
Cellular activation pathways and interaction networks in vascularized composite allotransplantation
Knoedler L, Knoedler S, Panayi A, Lee C, Sadigh S, Huelsboemer L, Stoegner V, Schroeter A, Kern B, Mookerjee V, Lian C, Tullius S, Murphy G, Pomahac B, Kauke-Navarro M. Cellular activation pathways and interaction networks in vascularized composite allotransplantation. Frontiers In Immunology 2023, 14: 1179355. PMID: 37266446, PMCID: PMC10230044, DOI: 10.3389/fimmu.2023.1179355.Peer-Reviewed Original ResearchConceptsVascularized Composite AllotransplantationComposite allotransplantationRecipient-derived lymphocytesTreatment of patientsCellular activation pathwaysMultidrug immunosuppressionVCA graftsVCA patientsVCA rejectionGraft rejectionDevastating injuriesClinical managementNovel therapiesReconstructive surgeryLimb lossRejection responseFacial disfigurementAllotransplantationPatientsGraftActivation pathwayTissue cellsDifferent cell typesTissue typesCell types
2013
Face time: educating face transplant candidates.
Lamparello B, Bueno E, Diaz-Siso J, Sisk G, Pomahac B. Face time: educating face transplant candidates. Eplasty 2013, 13: e36. PMID: 23861990, PMCID: PMC3704081.Peer-Reviewed Original ResearchSolid organ transplant programsFace transplantationComprehensive patient educationOrgan transplant programsMultidisciplinary education programSevere facial disfigurementQuality of lifeFace transplant candidatesTransplant patientsTransplant candidatesTransplant teamOptimal careTransplant programsPatient educationNovel therapiesMedication regimesPatient needsTransplantationInformed consentPatientsFacial disfigurementSupport groupsEducation programsStrong knowledge baseEducational component